US FDA update on nitrosamine impurities investigation

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1739卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57642-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[31] Update of US FDA's Total Diet Study food list and diets
Sara Kathleen Egan
Philip Michael Bolger
Clark Dewitt Carrington
Journal of Exposure Science & Environmental Epidemiology, 2007, 17 : 573 - 582
[32] EMA says Companies Should Test for Nitrosamine Impurities
不详
PHARMACEUTICAL MEDICINE, 2019, 33 (06) : 532 - 532
[33] EMA continues work to avoid nitrosamine impurities in sartans
Reactions Weekly, 2019, 1752 (1) : 4 - 4
[34] EMA says companies should test for nitrosamine impurities
Reactions Weekly, 2019, 1774 (1) : 2 - 2
[35] Nitrosamine impurities in medicines: safety concern addressed in Australia
Reactions Weekly, 2022, 1918 (1) : 6 - 6
[36] Apo-Amitriptyline recalled due to nitrosamine impurities
Reactions Weekly, 2024, 2033 (1) : 1 - 1
[37] Reflections on the Impact of Nitrosamine Drug Substance Related Impurities
Teasdale, Andrew
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (10) : 1685 - 1686
[38] FDA update: 1996
Oldham, RK
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1996, 11 (01) : 1 - 2
[39] FDA Oncology Update
不详
AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (04): : 198 - 200
[40] How to comply with FDA-imposed nitrosamine impurity testing
Walker, Michael
Manufacturing Chemist, 2020, 91 (06): : 32 - 34

← 1 2 3 4 5 →